iNtRON Biotechnology

iNtRON Biotechnology, Inc. is a biotechnology company based in Seongnam, South Korea, established in 1999. The company specializes in developing biopharmaceuticals aimed at preventing and treating infectious diseases globally. Its primary focus includes the creation of bacteriophage and endolysin-based therapeutics, as well as the development of molecular diagnostic assays. iNtRON manufactures diagnostic kits based on real-time PCR and multiplex PCR technologies, which are utilized for identifying infectious organisms, including various strains of bacteria and viruses such as swine flu and avian influenza. Additionally, the company is involved in veterinary health by providing alternatives to traditional antibiotics and is actively engaged in the development of novel biopharmaceutical products. Through its diverse offerings, iNtRON Biotechnology contributes significantly to public health and disease prevention efforts.